Graf Akcie TAK (Takeda Pharmaceutical Company L). Diskuze k akciím TAK. Aktuální informace TAK.

Základní informace o společnosti Takeda Pharmaceutical Company L (Akcie TAK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie TAK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$30,278.93$18,875.02$15,934.78$16,108.07$15,001.24$16,178.2
Cost Of Goods Sold$10,025.83$5,937.21$4,463.289$5,196.421$4,443.861$4,741.009
Gross Profit$20,253.1$12,937.81$11,471.49$10,911.65$10,557.38$11,437.19
Research And Development Expenses$4,529.905$3,314.682$2,928.969$2,904.418$2,871.194$3,477.073
SG&A Expenses$8,875.58$6,458.391$5,652.954$5,757.267$5,401.416$5,574.778
Other Operating Income Or Expenses$-1,733.997$510.336$385.713$657.064$-160.232$-1,956.291
Operating Expenses$29,355.18$17,030.29$13,758.68$14,658.51$13,915.37$17,354.41
Operating Income$923.754$1,844.721$2,176.102$1,449.563$1,085.872$-1,176.212
Total Non-Operating Income/Expense$-1,482.69$-990.657$-221.256$-116.455$-85.399$-147.274
Pre-Tax Income$-558.937$854.064$1,954.845$1,333.118$1,000.474$-1,323.477
Income Taxes$-966.405$-127.062$274.473$258.847$307.59$-21.867
Income After Taxes$407.468$981.126$1,680.372$1,074.271$692.884$-1,301.609
Other Income------
Income From Continuous Operations$407.468$981.126$1,680.372$1,074.271$692.884$-1,301.609
Income From Discontinued Operations------
Net Income$407.017$982.134$1,681.974$1,068.942$665.378$-1,326.552
EBITDA$6,293.325$4,296.734$3,815.245$3,521.483$2,724.134$1,198.442
EBIT$923.754$1,844.721$2,176.102$1,449.563$1,085.872$-1,176.212
Basic Shares Outstanding3,1141,9231,5621,5621,5681,573
Shares Outstanding3,1321,9341,5731,5721,5761,573
Basic EPS$0.13$0.51$1.08$0.68$0.42$-0.84
EPS - Earnings Per Share$0.13$0.51$1.07$0.68$0.42$-0.84
# 2020 2019 2018 2017 2016 2015
Current Ratio1.13491.2151.46280.92281.60261.4949
Long-term Debt / Capital0.4880.480.32820.23530.21160.222
Debt/Equity Ratio1.07741.11380.48860.58740.3820.3306
Gross Margin66.888468.544671.990367.740370.376670.6951
Operating Margin3.05089.773313.65638.9997.2386-7.2704
EBIT Margin3.05089.773313.65638.9997.2386-7.2704
EBITDA Margin20.784522.764123.942921.861618.15947.4078
Pre-Tax Profit Margin-1.8464.524812.26788.27616.6693-8.1806
Net Profit Margin1.34425.203410.55546.63614.4355-8.1996
Asset Turnover0.25670.15120.43120.39760.47260.4138
Inventory Turnover Ratio1.43470.66862.32892.46922.10781.9858
Receiveable Turnover4.1932.79964.12913.89424.19763.8083
Days Sales In Receivables87.0495130.376488.396793.729386.953895.8434
ROE - Return On Equity0.93692.11129.25485.92694.1507-6.4833
Return On Tangible Equity-1.2814-2.8255-715.2719-82.756517.08-32.1509
ROA - Return On Assets0.34540.78584.54672.65192.183-3.3293
ROI - Return On Investment0.47961.09796.21734.5323.2725-5.0442
Book Value Per Share13.9614.847311.619411.606310.652312.7077
Operating Cash Flow Per Share0.4383-0.63250.61481.4123-0.92180.1176
Free Cash Flow Per Share0.2275-0.39170.59561.3191-1.09280.2671